Author:
Li Yong-Shuang,Xie Qiang,Yang Da-Ye,Zheng Yuan
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,General Medicine
Reference43 articles.
1. Andersen JB, Factor VM, Marquardt JU, Raggi C, Lee YH, Seo D, Conner EA, Thorgeirsson SS (2010) An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer. Sci Transl Med 2:54ra77. doi: 10.1126/scitranslmed.3001338
2. Sherman M (2010) Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis 30:3–16. doi: 10.1055/s-0030-1247128
3. Chuang SC, La Vecchia C, Boffetta P (2009) Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett 286:9–14. doi: 10.1016/j.canlet.2008.10.040
4. Pan H, Fu X, Huang W (2011) Molecular mechanism of liver cancer. Anticancer Agents Med Chem 11:493–499. http://www.ncbi.nlm.nih.gov/pubmed/21554201
5. Arzumanyan A, Reis HM, Feitelson MA (2013) Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat Rev Cancer 13:123–135. doi: 10.1038/nrc3449
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献